| Ytd | -22.72% | |
| 1y | 27.51% |
| Open | 13.80 | Prev Close | 13.89 | Low | 13.60 | High | 13.80 | Mkt Cap | 964.45M |
| Vol | 4.50K | Avg Vol | 11.12K | EPS | 0.19 | P/E | 71.87 | Forward P/E | 32.70 |
| Beta | 0.12 | Short Ratio | 0.40 | Inst. Own | 0.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-31 | 50-d Avg | 13.79 | 200-d Avg | 15.63 | 1yr Est | 34.60 |
Pharming Group ((Euronext: PHARM, NASDAQ:PHAR) today announced that the U.S. Food and Drug Administr
Pharming (NASDAQ:PHAR) affirms FY2026 sales outlook from $405.000 million-$425.000 million to $405.0
U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ:
Shares of Kulicke & Soffa Industries (NASDAQ: VECO) rose after beating earnings estimates. Other
For 2026, the Company anticipates: Total revenues between US$405 million and US$425 million (8% to 1
Pharming (NASDAQ:PHAR) reported quarterly losses of $(0.07) per share which missed the analyst conse
Canaccord Genuity analyst Whitney Ijem initiates coverage on Pharming (NASDAQ:PHAR) with a Buy ra
If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union fo
HC Wainwright & Co. analyst Joseph Pantginis reiterates Pharming (NASDAQ:PHAR) with a Buy and
First approved treatment in Japan for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (AP
Oppenheimer analyst Jeff Jones reiterates Pharming (NASDAQ:PHAR) with a Outperform and lowers the
For 2026, the Company anticipates:Total revenues between US$405 million and US$425 million (8% to 1
Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.07 per share which beat the analyst consens
Highlights advancing clinical-stage pipeline, including two major value-creating programs for primar
FDA issued a CRL to Pharming's Joenja child use filing, citing dosing concerns in lower-weight k
Total 2025 revenues are estimated to be approximately US$376 million*, exceeding the upwardly revise
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.
Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announc
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for it
U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here ar
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnin
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enh
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings
Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead en
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report